Drug Approval | February 21, 2025
Korea’s MFDS completes inspection at Concord Biotech's Dholka unit
The inspection was successfully completed
The inspection was successfully completed
Theatre (OTs) dedicated to cataract, LASIK, and retina treatments added to meet the growing demand
The new facility, which has a capacity of 5,000 metric tonnes, will manufacture nutraceuticals and dietary-active ingredients for human consumption.
The Emcure Research Centre (ERC) will drive research across multiple dosage forms, including OSD, injectables, novel drug delivery systems (NDDS), inhalers and topical and transdermal formulations
The company has paid an Interim Environmental Damage Compensation of Rs. 3.40 lakh to GPCB
The TGA approval marks a pivotal step in Rusan Pharma’s expansion into the Australian market
This agreement reinforces Lubrizol’s commitment to Make-In-India and broadens a previously committed US$ 350 million investment to support local manufacturing
He specializes in financial planning, audit, compliance and ERP implementation, with extensive experience in leading automation and risk management projects
This approval reflects company’s unwavering commitment that the quality assurance
Fermenta Biotech’s API manufacturing facility receives EU GMP compliance certificate
Subscribe To Our Newsletter & Stay Updated
